Robert Saul
Nessuna posizione attualmente
Profilo
From 1983 to 1986, Dr. Saul was a postdoctoral fellow at the University of California at Berkeley in the Biochemistry Department, under the supervision of Professor Bruce Ames.
Here, Dr. Saul studied DNA chemistry and he published methods on the detection of metabolic products produced by oxidative damage to DNA.
1986, Dr. Saul founded Operon Technologies, Inc. He acted as President of Operon from 1986 to 1999, as CFO from 1995 to 1999, and as Chairman from 1986 to 2000.
In 2000, he played an active role in the merger between Operon and QIAGEN, Inc. Dr. Saul left Qiagen-Operon in December 2000.
In 2001, Dr. Saul founded Polymorphic DNA Technologies, Inc. He has made important contributions to Polymorphic’s novel PCR and sequencing methods.
He currently acts as the company’s President and Chairman.
Dr. Saul received a Bachelor of Science in Physics from the University of Waterloo (Canada) in 1978.
He received a Ph.D.
in Medical Biophysics from the University of Toronto in 1983.
His doctoral research was on human metabolism of nitrates and nitrites, and his published work played a key role in the debate regarding the use of nitrites as a food additive.
Precedenti posizioni note di Robert Saul
Società | Posizione | Fine |
---|---|---|
Qiagen, Inc.
Qiagen, Inc. Miscellaneous Commercial ServicesCommercial Services Qiagen, Inc. provided technologies for separating, purifying and handling nucleic acids. The company was founded in 1988 and was headquartered in Germantown, MD. | Corporate Officer/Principal | 31/12/2000 |
QIAGEN Operon, Inc.
QIAGEN Operon, Inc. Medical SpecialtiesHealth Technology Part of QIAGEN NV, QIAGEN Operon, Inc. develops and sells DNA segments. The company is based in Alameda, CA. QIAGEN Operon was acquired by QIAGEN NV on June 29, 2000 for $117.57 million. | Corporate Officer/Principal | 31/12/1999 |
Archangel Bioventures LLC
Archangel Bioventures LLC Investment ManagersFinance Archangel Bioventures LLC operated as venture capital/private equity. The company was founded by Grant R. Campany, Robert Saul, Bruce N. Ames and Nathan D. Hamilton in 2000 and was headquartered in Incline Village, NV. | Fondatore | - |
Formazione di Robert Saul
University of Toronto | Doctorate Degree |
The University of Waterloo | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 3 |
---|---|
QIAGEN Operon, Inc.
QIAGEN Operon, Inc. Medical SpecialtiesHealth Technology Part of QIAGEN NV, QIAGEN Operon, Inc. develops and sells DNA segments. The company is based in Alameda, CA. QIAGEN Operon was acquired by QIAGEN NV on June 29, 2000 for $117.57 million. | Health Technology |
Qiagen, Inc.
Qiagen, Inc. Miscellaneous Commercial ServicesCommercial Services Qiagen, Inc. provided technologies for separating, purifying and handling nucleic acids. The company was founded in 1988 and was headquartered in Germantown, MD. | Commercial Services |
Archangel Bioventures LLC
Archangel Bioventures LLC Investment ManagersFinance Archangel Bioventures LLC operated as venture capital/private equity. The company was founded by Grant R. Campany, Robert Saul, Bruce N. Ames and Nathan D. Hamilton in 2000 and was headquartered in Incline Village, NV. | Finance |
- Borsa valori
- Insiders
- Robert Saul